Richard Newitter
Stock Analyst at Truist Securities
(4.19)
# 461
Out of 5,102 analysts
421
Total ratings
52.4%
Success rate
13.85%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Hold | $90 → $92 | $84.24 | +9.21% | 22 | Dec 5, 2025 | |
| INSP Inspire Medical Systems | Upgrades: Buy | $128 → $165 | $137.37 | +20.11% | 29 | Nov 26, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $88 → $86 | $72.34 | +18.88% | 11 | Nov 24, 2025 | |
| PODD Insulet | Maintains: Buy | $390 → $412 | $294.17 | +40.06% | 3 | Nov 21, 2025 | |
| MDT Medtronic | Maintains: Hold | $103 → $110 | $99.75 | +10.28% | 18 | Nov 20, 2025 | |
| GMED Globus Medical | Reiterates: Buy | $93 → $105 | $88.88 | +18.14% | 29 | Nov 18, 2025 | |
| SYK Stryker | Maintains: Hold | $392 → $400 | $352.97 | +13.32% | 24 | Nov 14, 2025 | |
| VCEL Vericel | Reiterates: Buy | $41 → $50 | $37.41 | +33.65% | 5 | Nov 10, 2025 | |
| TMCI Treace Medical Concepts | Reiterates: Hold | $7 → $4 | $2.91 | +37.46% | 17 | Nov 10, 2025 | |
| TNDM Tandem Diabetes Care | Reiterates: Hold | $16 → $17 | $20.97 | -18.93% | 3 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $63 → $61 | $63.10 | -3.33% | 20 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 → $20 | $13.12 | +52.44% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $94 → $82 | $68.94 | +18.94% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 → $32 | $29.31 | +9.18% | 4 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $129 → $130 | $91.75 | +41.69% | 19 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $620 | $547.36 | +13.27% | 31 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $50 | $36.03 | +38.77% | 15 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $300 | $311.40 | -3.66% | 6 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $205 | $169.10 | +21.23% | 17 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $14.05 | +6.76% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $126 → $120 | $109.23 | +9.86% | 6 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $127.25 | +7.66% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $18.33 | +30.93% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $92.45 | +22.23% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $18.82 | +11.58% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $13.09 | +52.79% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $78.76 | +4.11% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $200.43 | +24.73% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $4.77 | +445.07% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $163.87 | +369.88% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $74.83 | +13.59% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $11.53 | +73.46% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $29.98 | -9.94% | 5 | Feb 23, 2021 |
Edwards Lifesciences
Dec 5, 2025
Maintains: Hold
Price Target: $90 → $92
Current: $84.24
Upside: +9.21%
Inspire Medical Systems
Nov 26, 2025
Upgrades: Buy
Price Target: $128 → $165
Current: $137.37
Upside: +20.11%
Integer Holdings
Nov 24, 2025
Maintains: Buy
Price Target: $88 → $86
Current: $72.34
Upside: +18.88%
Insulet
Nov 21, 2025
Maintains: Buy
Price Target: $390 → $412
Current: $294.17
Upside: +40.06%
Medtronic
Nov 20, 2025
Maintains: Hold
Price Target: $103 → $110
Current: $99.75
Upside: +10.28%
Globus Medical
Nov 18, 2025
Reiterates: Buy
Price Target: $93 → $105
Current: $88.88
Upside: +18.14%
Stryker
Nov 14, 2025
Maintains: Hold
Price Target: $392 → $400
Current: $352.97
Upside: +13.32%
Vericel
Nov 10, 2025
Reiterates: Buy
Price Target: $41 → $50
Current: $37.41
Upside: +33.65%
Treace Medical Concepts
Nov 10, 2025
Reiterates: Hold
Price Target: $7 → $4
Current: $2.91
Upside: +37.46%
Tandem Diabetes Care
Nov 10, 2025
Reiterates: Hold
Price Target: $16 → $17
Current: $20.97
Upside: -18.93%
Nov 10, 2025
Reiterates: Hold
Price Target: $63 → $61
Current: $63.10
Upside: -3.33%
Nov 7, 2025
Reiterates: Buy
Price Target: $18 → $20
Current: $13.12
Upside: +52.44%
Nov 3, 2025
Reiterates: Buy
Price Target: $94 → $82
Current: $68.94
Upside: +18.94%
Oct 29, 2025
Reiterates: Buy
Price Target: $28 → $32
Current: $29.31
Upside: +9.18%
Oct 23, 2025
Maintains: Buy
Price Target: $129 → $130
Current: $91.75
Upside: +41.69%
Oct 22, 2025
Maintains: Buy
Price Target: $525 → $620
Current: $547.36
Upside: +13.27%
Oct 15, 2025
Maintains: Buy
Price Target: $64 → $50
Current: $36.03
Upside: +38.77%
Oct 15, 2025
Maintains: Buy
Price Target: $310 → $300
Current: $311.40
Upside: -3.66%
Oct 15, 2025
Maintains: Buy
Price Target: $175 → $205
Current: $169.10
Upside: +21.23%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $14.05
Upside: +6.76%
Sep 22, 2025
Maintains: Buy
Price Target: $126 → $120
Current: $109.23
Upside: +9.86%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $127.25
Upside: +7.66%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $18.33
Upside: +30.93%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $92.45
Upside: +22.23%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $18.82
Upside: +11.58%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $13.09
Upside: +52.79%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $78.76
Upside: +4.11%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $200.43
Upside: +24.73%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $4.77
Upside: +445.07%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $163.87
Upside: +369.88%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $74.83
Upside: +13.59%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $11.53
Upside: +73.46%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $29.98
Upside: -9.94%